FilingReader Intelligence
Takeda reports revenue decline but profit surge in Q1
July 30, 2025 at 12:05 PM UTC•By FilingReader AI
Takeda Pharmaceutical reported Q1 revenue of 1,106.7bn yen, down 8.4% year-over-year, hit by unfavorable foreign exchange rates and declining neuroscience sales.
Operating profit rose 11% to 184.6bn yen, while net profit surged 30.4% to 124.2bn yen. The revenue decline was partly driven by generic erosion of VYVANSE in the U.S.
Full-year guidance remains unchanged across core revenue, operating profit and earnings per share.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
TSE:4502•Tokyo Stock Exchange
News Alerts
Get instant email alerts when Takeda Pharmaceutical Company Limited publishes news
Free account required • Unsubscribe anytime